Reply Risk Scores From PARIS Registry: Are They Useful in a Contemporary Cohort of ACS Patients?

We appreciate the comments and concerns raised by Dr. Raposeiras-Roubin and colleagues regarding the PARIS (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) risk scores for coronary thrombosis and major bleeding following percutaneous coronary intervention (PCI) with drug eluting stents that we recently reported in theJournal(1). We agree with the authors that evaluating model performance in patients with acute coronary syndrome or sustaining early events within the first year are important considerations. Accordingly, we have provided metrics of model performance according to these parameters inTable  1. Both models show comparable levels of discrimination to each another and are consistent with the findings in our primary paper.
Source: Journal of the American College of Cardiology - Category: Cardiology Source Type: research